Cardiac Magnetic Resonance for Prophylactic Implantable-Cardioverter Defibrillator Therapy in Ischemic Cardiomyopathy: The DERIVATE–ICM International Registry

Cardiac Magnetic Resonance for Prophylactic Implantable-Cardioverter Defibrillator Therapy in Ischemic Cardiomyopathy: The DERIVATE–ICM International Registry - JIMG November 2023

Description

ICD therapy is the most effective sudden cardiac death (SCD) event prophylactic-strategy in ICM patients with TTE left ventricle ejection fraction (LVEF)≤35%. This approach has been recently questioned due to the low rate of ICD interventions in patients who received implantation and the not negligible percentage of patients who experienced SCD event despite not fulfilling criteria for implantation.

Editors
Editor-in-Chief
Y.S. Chandrashekhar, MD, DM, FACC

CME Editor
Kenneth A. Ellenbogen, MD

Author
Talal Alnabelsi, MD, FACC

Important Dates
Date of Release: November 6, 2023
Term of Approval/Date of CME/MOC Expiration: November 5, 2024

Summary

Availability:

Retired

Cost:

FREE

Credit Offered:

No Credit Offered